Molecular characterisation of two mumps virus genotypes circulating during an epidemic in Lithuania from 1998 to 2000

T Tecle1, A Mickiené, B Johansson

  • 1Department of Clinical Virology, Huddinge University Hospital, Karolinska Institute, Stockholm, Sweden.

Archives of Virology
|March 14, 2002
PubMed

Insights

Mumps outbreaks can be severe, causing complications like meningitis and orchitis. Genotyping revealed specific C genotype variants linked to disease severity, potentially indicating lower neurovirulence.

Area of Science:

  • Virology
  • Epidemiology
  • Molecular Biology

Background:

  • A significant mumps epidemic occurred in Lithuania from December 1998 to May 2000, affecting approximately 11,000 individuals.
  • Mumps complications, including meningitis and orchitis, were observed in a notable proportion of cases during this epidemic.

Purpose of the Study:

  • To genotype mumps virus strains responsible for the Lithuanian epidemic.
  • To investigate potential correlations between specific viral genotypes and clinical manifestations, such as meningitis and orchitis.
  • To identify molecular markers associated with mumps virus virulence.

Main Methods:

  • Virus samples were collected from 80 patients with parotitis in Kaunas.
  • Nucleotide sequencing of the small hydrophobic (SH) protein gene was performed on 27 virus strains.
  • Phylogenetic analysis was used to determine viral genotypes and their relationships.

Main Results:

  • Twenty-five of the 27 genotyped strains belonged to genotype C, and two belonged to genotype D.
  • Meningitis cases were associated with a distinct cluster (C1) within genotype C.
  • A novel variant of genotype C, designated C2, was identified with a specific amino acid substitution (Val-Ala-Ser) and was associated with parotitis, potentially indicating lower neurovirulence.

Conclusions:

  • The study identified specific genotype C variants (C1 and C2) of the mumps virus circulating during the Lithuanian epidemic.
  • The C2 genotype, characterized by an alanine at position 29 and serine at position 48 in the SH protein, may serve as a marker for reduced neurovirulence.
  • Genotyping provides valuable insights into the molecular epidemiology and virulence factors of mumps virus.